HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cohen, D. J. Articles by Zajtchuk, R. Search for Related Content PubMed PubMed Citation Articles by Cohen, D. J. Articles by Zajtchuk, R.

The Journal of Thoracic and Cardiovascular Surgery, Vol 87, 301-307, Copyright © 1984 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Management of patients with malignant thymoma

DJ Cohen, LD Ronnigen, GM Graeber, JL Deshong, J Jaffin, JR Burge and R Zajtchuk

This report documents the results of therapy in 23 patients treated for malignant thymoma between 1944 and 1979. Of the group, 22 patients had neoplasms which invaded mediastinal structures; six had distant metastases. Four patients had myasthenia gravis and one had erythroid hypoplasia associated with collagen vascular disease. No deaths were associated with primary therapy, which included an operative procedure in all cases. Follow-up ranged from 4 months to 18 years (mean 5.63 +/- 1.03 years, SEM). Fifteen patients died, with postoperative survival times ranging from 4 months to 18 years (mean 3.8 +/- 1.27 years). Five patients were alive without recurrence from 3 to 11 years postoperatively (mean 6.8 +/- 1.36 years), and three patients were alive with recurrence or distant metastases from 4 to 17 years postoperatively (mean 10.75 +/- 2.66 years). Differences in survival on the basis of tumor cell type were not statistically significant. Therapeutic groups were analyzed for 5 year survivors, tumor deaths within 5 years of therapy, deaths due to other causes, deaths due to tumor after 5 years, those presently alive, and longest known survivor. The data suggest that complete surgical excision offers the best chance of long-term survival when compared to partial resection plus irradiation (p less than 0.05). No statistical significance could be demonstrated between the groups who had complete resection with versus without postoperative irradiation. There also was no statistically significant difference between the group of patients receiving irradiation following partial excision of most of their tumor and the group receiving irradiation following only biopsy of the lesion. This observation suggests there is no value in so-called "debulking procedures" and suggests that irradiation may be of value in local control of thymoma. Perpetual surveillance is necessary since late recurrence is common.

This article has been cited by other articles:

				B. V. Duwe, D. H. Sterman, and A. I. Musani Tumors of the Mediastinum Chest, October 1, 2005; 128(4): 2893 - 2909. [Abstract] [Full Text] [PDF]

				J. Nakajima, J. Matsumoto, E. Takeuchi, T. Fukami, and S. Takamoto Rearrangement of T-Cell Receptor Beta and Gamma Genes in Thymoma Asian Cardiovasc Thorac Ann, June 1, 2005; 13(2): 149 - 152. [Abstract] [Full Text] [PDF]

				S. Singhal, J. B. Shrager, D. I. Rosenthal, V. A. LiVolsi, and L. R. Kaiser Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation Ann. Thorac. Surg., November 1, 2003; 76(5): 1635 - 1642. [Abstract] [Full Text] [PDF]

				K. Kondo and Y. Monden Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan Ann. Thorac. Surg., September 1, 2003; 76(3): 878 - 884. [Abstract] [Full Text] [PDF]

				S. B. Johnson, T. Y. Eng, G. Giaccone, and C. R. Thomas Jr. Thymoma: Update for the New Millenium Oncologist, June 1, 2001; 6(3): 239 - 246. [Abstract] [Full Text] [PDF]

				C. R. Thomas, C. D. Wright, and P. J. Loehrer Thymoma: State of the Art J. Clin. Oncol., July 1, 1999; 17(7): 2280 - 2280. [Abstract] [Full Text] [PDF]

				M. Okumura, S. Miyoshi, Y. Takeuchi, H.-E. Yoon, M. Minami, S.-I. Takeda, Y. Fujii, K. Nakahara, and H. Matsuda Results Of Surgical Treatment Of Thymomas With Special Reference To The Involved Organs J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 605 - 611. [Abstract] [Full Text]

				S. Fujino, N. Tezuka, S. Watarida, K. Katsuyama, S. Inoue, and A. Mori Reconstruction of the aortic arch in invasive thymoma under retrograde cerebral perfusion Ann. Thorac. Surg., July 1, 1998; 66(1): 263 - 264. [Abstract] [Full Text] [PDF]

				K. Yagi, T. Hirata, T. Fukuse, H. Yokomise, K. Inui, O. Ike, H. Mizuno, M. Aoki, S. Hitomi, and H. Wada Surgical Treatment for Invasive Thymoma, Especially When the Superior Vena Cava Is Invaded Ann. Thorac. Surg., February 1, 1996; 61(2): 521 - 524. [Abstract] [Full Text]